Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael B Murphy

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|March 11, 2010
KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER studyOlga A Iakoubova, Michele Robertson, Carmen H Tong, et al.
ACS Bio & Med Chem Au|December 25, 2023
The C-Terminal of Na<sub>V</sub>1.7 Is Ubiquitinated by NEDD4LKatharine M Wright, Hanjie Jiang, Wendy Xia, et al.
Allergy|February 20, 2022
Anti-KIT monoclonal antibody CDX-0159 induces profound and durable mast cell suppression in a healthy volunteer studyDiego Alvarado, Marcus Maurer, Richard Gedrich, et al.
Atherosclerosis|February 12, 2008
Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly populationEliana Polisecki, Inga Peter, Michele Robertson, et al.
Allergy|February 20, 2025
Dual Inhibition of Mast Cells and Thymic Stromal Lymphopoietin Using a Novel Bispecific Antibody, CDX-622Michael B Murphy, Laura Vitale, Thomas O'Neill, et al.
Plos Medicine|June 26, 2009
Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?Naveed Sattar, Heather M Murray, Paul Welsh, et al.
Journal of Neurology|August 5, 2009
Pravastatin and cognitive function in the elderly. Results of the PROSPER studyStella Trompet, Peter van Vliet, Anton J M de Craen, et al.
Current Controlled Trials in Cardiovascular Medicine|July 5, 2002
A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline CharacteristicsIan Ford, Gerard Jan Blauw, Michael B Murphy, et al.
Lancet (London, England)|May 27, 2008
Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studiesNaveed Sattar, Alex McConnachie, A Gerald Shaper, et al.
Circulation|November 9, 2005
Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)Chris J Packard, Ian Ford, Michele Robertson, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
European Journal of Cardiovascular Prevention and Rehabilitation : Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology|March 11, 2010
KIF6 Trp719Arg polymorphism and the effect of statin therapy in elderly patients: results from the PROSPER studyOlga A Iakoubova, Michele Robertson, Carmen H Tong, et al.
ACS Bio & Med Chem Au|December 25, 2023
The C-Terminal of Na<sub>V</sub>1.7 Is Ubiquitinated by NEDD4LKatharine M Wright, Hanjie Jiang, Wendy Xia, et al.
Allergy|February 20, 2022
Anti-KIT monoclonal antibody CDX-0159 induces profound and durable mast cell suppression in a healthy volunteer studyDiego Alvarado, Marcus Maurer, Richard Gedrich, et al.
Atherosclerosis|February 12, 2008
Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly populationEliana Polisecki, Inga Peter, Michele Robertson, et al.
Allergy|February 20, 2025
Dual Inhibition of Mast Cells and Thymic Stromal Lymphopoietin Using a Novel Bispecific Antibody, CDX-622Michael B Murphy, Laura Vitale, Thomas O'Neill, et al.
Plos Medicine|June 26, 2009
Are markers of inflammation more strongly associated with risk for fatal than for nonfatal vascular events?Naveed Sattar, Heather M Murray, Paul Welsh, et al.
Journal of Neurology|August 5, 2009
Pravastatin and cognitive function in the elderly. Results of the PROSPER studyStella Trompet, Peter van Vliet, Anton J M de Craen, et al.
Current Controlled Trials in Cardiovascular Medicine|July 5, 2002
A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline CharacteristicsIan Ford, Gerard Jan Blauw, Michael B Murphy, et al.
Lancet (London, England)|May 27, 2008
Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studiesNaveed Sattar, Alex McConnachie, A Gerald Shaper, et al.
Circulation|November 9, 2005
Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)Chris J Packard, Ian Ford, Michele Robertson, et al.
Pageof 4